ArticleResearch and practice in thrombosis and haemostasis2026
Thrombin kinetics determines robust plasma clot architecture.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Altered fibrin clot architecture is a distinct signature in cardiovascular diseases. To determine the origin and importance of these alterations, a fundamental understanding of normal plasma clotting mechanisms is essential. While biochemical and structural aspects of fibrin formation are individually well documented, their mechanistic link lacks a quantitative description. Objectives: This study addresses two questions: How does fibrin architecture vary with tissue factor concentration ([TF]) in normal plasma, and can a simple mechanistic relationship between fibrin structure and thrombin generation be extracted? Methods: The structuring of clots formed in TF-triggered normal pooled plasma and IIa-triggered fibrinogen was compared by varying the trigger concentrations. Architecture was quantified using confocal microscopy (pore size) and fibrinography (nanostructure). Thrombin kinetics were monitored using thrombinography. Results: Although purified and plasma clots appeared morphologically identical, their ultrastructural parameters showed fundamentally different sensitivities to trigger concentrations. In purified systems, a 100-fold [IIa] increase induced a 30-fold decrease in protofibril number ( Conclusions: Our findings show that the unique functional shape of the thrombin burst, rather than the trigger concentration, governs plasma fibrin architecture. This inherent robustness supports the existence of a "normal" clot structure and the potential of fibrinography as a robust structural biomarker candidate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.